| Primary |
| Pneumonia |
38.5% |
| Breast Cancer Metastatic |
15.4% |
| Gastric Ulcer Haemorrhage |
7.7% |
| Ischaemic Heart Disease Prophylaxis |
7.7% |
| Pain |
7.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
7.7% |
| Pyrexia |
7.7% |
| Renal Failure Chronic |
7.7% |
|
| Drug Interaction |
50.0% |
| Pseudomembranous Colitis |
50.0% |
|
| Secondary |
| Therapeutic Embolisation |
15.4% |
| Prophylaxis |
9.1% |
| Infection |
8.0% |
| Colitis Ulcerative |
6.6% |
| Pneumonia |
5.9% |
| Bronchitis |
4.9% |
| Pain |
4.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.9% |
| Analgesic Therapy |
4.5% |
| Infection Prophylaxis |
4.2% |
| Angiogram |
3.8% |
| Depression |
3.5% |
| Hypertension |
3.5% |
| Pyrexia |
3.5% |
| Analgesia |
3.1% |
| Constipation |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Pneumonia Mycoplasmal |
2.8% |
| Drug Use For Unknown Indication |
2.4% |
| Renal Failure Chronic |
2.4% |
|
| Scintillating Scotoma |
12.2% |
| Pancytopenia |
8.2% |
| Hepatic Function Abnormal |
6.1% |
| Premature Rupture Of Membranes |
6.1% |
| Pseudomembranous Colitis |
6.1% |
| Abnormal Sensation In Eye |
4.1% |
| Anaemia Haemolytic Autoimmune |
4.1% |
| Clostridium Difficile Colitis |
4.1% |
| Confusional State |
4.1% |
| Drug Eruption |
4.1% |
| Liver Disorder |
4.1% |
| Pneumonia |
4.1% |
| Pneumonia Aspiration |
4.1% |
| Post Procedural Infection |
4.1% |
| Respiratory Failure |
4.1% |
| Restlessness |
4.1% |
| Stevens-johnson Syndrome |
4.1% |
| Toxic Epidermal Necrolysis |
4.1% |
| Tubulointerstitial Nephritis |
4.1% |
| Urticaria |
4.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.1% |
| Drug Use For Unknown Indication |
12.4% |
| Prophylaxis |
10.2% |
| Psoriatic Arthropathy |
5.4% |
| Prophylaxis Against Transplant Rejection |
4.1% |
| Hypertension |
3.9% |
| Pneumonia |
3.0% |
| Gastroenteritis |
2.6% |
| Infection |
2.6% |
| Infection Prophylaxis |
2.5% |
| Rheumatoid Arthritis |
2.3% |
| Sedation |
2.2% |
| Pulmonary Arterial Hypertension |
2.1% |
| Postoperative Fever |
1.8% |
| Analgesic Therapy |
1.7% |
| Asthma |
1.7% |
| Diarrhoea |
1.7% |
| Pyrexia |
1.7% |
| Antipyresis |
1.6% |
| Colorectal Cancer |
1.6% |
|
| Interstitial Lung Disease |
9.9% |
| Infection |
7.4% |
| Pyrexia |
7.4% |
| Renal Failure Acute |
7.4% |
| Pneumonia |
6.2% |
| Respiratory Failure |
6.2% |
| White Blood Cell Count Increased |
6.2% |
| Liver Disorder |
4.9% |
| Cytomegalovirus Infection |
3.7% |
| Hypertension |
3.7% |
| Oxygen Saturation Decreased |
3.7% |
| Pulmonary Alveolar Haemorrhage |
3.7% |
| Renal Impairment |
3.7% |
| Rhabdomyolysis |
3.7% |
| Septic Shock |
3.7% |
| Skin Disorder |
3.7% |
| Swelling |
3.7% |
| Tooth Extraction |
3.7% |
| Upper Respiratory Tract Inflammation |
3.7% |
| Urinary Tract Infection Enterococcal |
3.7% |
|
| Interacting |
| Pneumonia |
28.8% |
| Breast Cancer Metastatic |
11.5% |
| Hypertension |
11.5% |
| Ischaemic Heart Disease Prophylaxis |
11.5% |
| Dementia |
5.8% |
| Gastric Ulcer Haemorrhage |
5.8% |
| Pain |
5.8% |
| Peripheral Arterial Occlusive Disease |
5.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.8% |
| Renal Failure Chronic |
5.8% |
| Parkinsonism |
1.9% |
|
| Dry Mouth |
42.9% |
| Pseudomembranous Colitis |
28.6% |
| Urinary Tract Infection |
14.3% |
| White Blood Cell Count Decreased |
14.3% |
|
